Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients

NCT04488081 is registered in ClinicalTrials.gov with QuantumLeap Healthcare Collaborative as lead sponsor.

NCT NCT04488081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04488081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Lead sponsor
QuantumLeap Healthcare Collaborative
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 31, 2020
Completion date
July 31, 2030
Enrollment
1,500 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19